Azafaros
Azafaros B.V. aims at developing new therapeutic agents for the treatment of rare metabolic disorders.
Azafaros has raised €157M across 2 funding rounds from 8 investors, most recently a Series B round in May 2025. Based in Leiden, Netherlands; active in Healthtech. Data as of 28 Oct 2026.
Leiden, Netherlandswww.azafaros.com ↗
Total raised
€157M
€157,188,917
Funding rounds
2
Investors
8
distinct backers
Active since
2020-06
latest 2025-05
Funding by year
EUR raised per yearAzafaros — funding by year — interactive chart.
Data table
| Azafaros — funding by year | |
|---|---|
| 2020 | €25M |
| 2025 | €132M |
Signals
High confidenceRaise-next likelihood77
base rate 48% for Series B
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood21
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 6y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-14 | Series B | €132M | BioGeneration Ventures (BGV),Forbion Growth,Forbion,Jeito Capital,Pictet,Schroders Capital+1 more | View deal → |
| 2020-06-02 | Series A | €25M | Forbion | View deal → |
Investors
8Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData